IBM
78
-3
BXP
59
2
ED
55
3
HBAN
47
2
ZBH
53
-3
MO
48
12
SHW
71
-2
MUR
48
4
CVS
58
6
TXT
60
4
CL
62
3
INTU
58
-5
TJX
51
-3
FE
56
4
UA
59
2
PEG
74
2
CMCSA
59
2
V
42
4
CTAS
53
-8
DVA
75
2
IBM
78
-3
BXP
59
2
ED
55
3
HBAN
47
2
ZBH
53
-3
MO
48
12
SHW
71
-2
MUR
48
4
CVS
58
6
TXT
60
4
CL
62
3
INTU
58
-5
TJX
51
-3
FE
56
4
UA
59
2
PEG
74
2
CMCSA
59
2
V
42
4
CTAS
53
-8
DVA
75
2
Financhill
Back

Nuveen S&P 500 Dynamic Overwrite Fund Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
32

SPXX
Nuveen S&P 500 Dynamic Overwrite Fund

Last Price:
16.58
Seasonality Move:
0.69%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
54.41
Seasonality Move:
7.55%
Sell
32
Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is a Sell

Is Nuveen S&P 500 Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen S&P 500 Dynamic Overwrite Fund [SPXX] share price is $16.61. The Score for SPXX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • SPXX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPXX Stock Price Chart

What is Nuveen S&P 500 Dynamic Overwrite Fund's stock price today?

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $54.43
    The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

SPXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 56.71 Buy
Chaikin Money Flow: 5438 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.4 - 16.64) Buy
Bollinger Bands (100): (15.86 - 16.54) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.8 Buy
Relative Strength Index (14 RSI): 43.18 Sell
Chaikin Money Flow: -435004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.76 - 58.26) Sell
Bollinger Bands (100): (40.14 - 54.08) Buy

SPXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.55 Buy
20-day SMA: 16.49 Buy
50-day SMA: 16.33 Buy
200-day SMA: 15.73 Buy
8-day EMA: 16.56 Buy
20-day EMA: 16.51 Buy
50-day EMA: 16.38 Buy
200-day EMA: 15.89 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.08 Sell
20-day SMA: 56.96 Sell
50-day SMA: 52.99 Buy
200-day SMA: 46.88 Buy
8-day EMA: 56.5 Sell
20-day EMA: 56.46 Sell
50-day EMA: 53.4 Buy
200-day EMA: 47.32 Buy

Nuveen S&P 500 Dynamic Overwrite Fund Earnings Growth & SPXX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

Nuveen S&P 500 Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):